Young John D's Form 4 filing
Pfizer Inc (PFE) · filed Nov 12, 2021
- Accession no.
- 0001225208-21-013850
- Filed
- Nov 12, 2021
- Trade date
- Nov 11, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 11 non-derivative transactions. Open-market sales total $7.51M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Young John DCIK 0001551792 | Officer (Group President) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2021 | Common Stock | SSaleDisposed | −2,800 | $50.16 | −$140,448 | 459,904 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −3,200 | $50.09 | −$160,288 | 456,704 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −4,200 | $50.03 | −$210,126 | 452,504 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −6,200 | $50.06 | −$310,372 | 446,304 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −9,100 | $50.14 | −$456,274 | 437,204 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −9,500 | $50.15 | −$476,425 | 427,704 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −9,818 | $50.07 | −$491,587.26 | 417,886 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −11,700 | $50.10 | −$586,170 | 406,186 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −15,500 | $50.12 | −$776,860 | 390,686 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −30,200 | $50.02 | −$1,510,604 | 360,486 | Direct | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −47,782 | $50.01 | −$2,389,577.82 | 312,704 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.